Routine Maternal Vaccine Uptake during the COVID-19 Pandemic

Abstract

Objective This study examines the impact of the coronavirus disease 2019 (COVID-19) pandemic on influenza and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine uptake in a pregnant, low-income population.

Study Design This retrospective cohort study included women initiating prenatal care before (May–November 2019) or during the COVID-19 pandemic (May–November 2020) at two large Medicaid clinics. All patients entered prenatal care before 20 weeks and delivered full-term. Medical records were reviewed for vaccine uptake and demographic data. Multivariate logistic regression analysis was used to compare vaccination rates prior to and during the COVID-19 pandemic. Additional analysis was performed to identify association of demographic factors with vaccine uptake. IRB approval was obtained for this study.

Results A total of 939 patients met inclusion criteria, with 462 initiating care prior to and 477 initiating care during the COVID-19 pandemic. Influenza vaccination uptake was 78% (362/462) in the prepandemic group, significantly decreasing to 61% (291/477) in the pandemic group (p <0.01, odds ratio [OR] = 0.38, confidence interval [CI]: 0.26–0.53). Tdap vaccination uptake was 85% (392/462) in the prepandemic group, significantly decreasing to 76% (361/477) in the pandemic group (p <0.01, OR = 0.56, CI: 0.40–0.79). The decrease in influenza vaccine uptake was most significant in non-Hispanic Black patients, decreasing from 64% (73/114) in the prepandemic group to 35% (35/101) in the pandemic group (p <0.01, OR = 0.30, CI: 0.17–0.52), while there was no significant difference in age or parity in relation to vaccination status.

Conclusion Routine vaccination uptake significantly decreased during the COVID-19 pandemic in a low-income population of pregnant women, with decrease more pronounced on influenza vaccine than on Tdap vaccine uptake, especially in non-Hispanic Black patients.

Key Points

• Influenza and Tdap vaccination uptake during pregnancy has decreased during the COVID-19 pandemic.

• Influenza vaccine uptake decreased more than Tdap in pregnancy during the COVID-19 pandemic.

• The greatest decrease was seen in influenza vaccine uptake in non-Hispanic Black patients.

Keywords

vaccination - TDAP - influenza - COVID-19 - vaccine nonreceipt

Publication History

Received: 04 April 2022

Accepted: 12 July 2022

Accepted Manuscript online:
20 July 2022

Article published online:
29 September 2022

• References

• 1 Ghaswalla P, Poirrier JEM, Packnett ER, Irwin DE, Gray SR, Buck PO. Maternal immunization in the U.S.: a nationwide retrospective cohort study. Am J Prev Med 2019; 57 (03) e87-e93
• 2 Razzaghi H, Kahn KE, Black CL. et al. Influenza and Tdap vaccination coverage among pregnant women - United States, April 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (39) 1391-1397
• 3 Núñez A, Sreeganga SD, Ramaprasad A. Access to healthcare during COVID-19. Int J Environ Res Public Health 2021; 18 (06) 2980
• 4 Goncu Ayhan S, Oluklu D, Atalay A. et al. COVID-19 vaccine acceptance in pregnant women. Int J Gynaecol Obstet 2021; 154 (02) 291-296
• 5 Dinleyici EC, Borrow R, Safadi MAP, van Damme P, Munoz FM. Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum Vaccin Immunother 2021; 17 (02) 400-407
• 6 Bramer CA, Kimmins LM, Swanson R. et al. Decline in child vaccination coverage during the COVID-19 pandemic - Michigan Care Improvement Registry, May 2016-May 2020. Am J Transplant 2020; 20 (07) 1930-1931
• 7 Naidu SAG, Clemens RA, Pressman P. et al. COVID-19 during pregnancy and postpartum. J Diet Suppl 2022; 19 (01) 115-142
• 8 Saso A, Skirrow H, Kampmann B. Impact of COVID-19 on immunization services for maternal and infant vaccines: results of a survey conducted by imprint-the immunising pregnant women and infants network. Vaccines (Basel) 2020; 8 (03) 556
• 9 Domnich A, Cambiaggi M, Vasco A. et al. Attitudes and beliefs on influenza vaccination during the COVID-19 pandemic: results from a representative Italian Survey. Vaccines (Basel) 2020; 8 (04) E711
• 10 Kahn KE, Razzaghi H, Jatlaoui TC. et al. Flu and Tdap vaccination coverage among pregnant women – United States. Accessed August 17, 2022 at: https://www.cdc.gov/flu/fluvaxview/pregnant-women-apr2021.htm#
• 11 Melber DJ, Brodsky AL, Rocha CN, McIntyre BB, Jacobs MB, Ramos GA. Vaccination uptake in pregnancy: before and after the start of the COVID-19 pandemic. Am J Obstet Gynecol 2022; 226 (01) S449
• 12 Qiu X, Bailey H, Thorne C. Barriers and facilitators associated with vaccine acceptance and uptake among pregnant women in high income countries: a mini-review. Front Immunol 2021; 12: 626717
• 13 Giles ML, Gunatilaka A, Palmer K, Sharma K, Roach V. Alignment of national COVID-19 vaccine recommendations for pregnant and lactating women. Bull World Health Organ 2021; 99 (10) 739-746
• 14 Razzaghi H, Meghani M, Pingali C. et al. COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. MMWR Morb Mortal Wkly Rep 2021; 70 (24) 895-899
• 15 Battarbee AN, Stockwell MS, Varner M. et al. Attitudes toward COVID-19 illness and COVID-19 vaccination among pregnant women: a cross-sectional multicenter study during August-December 2020. Am J Perinatol 2022; 39 (01) 75-83
• 16 Sutton D, D'Alton M, Zhang Y. et al. COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women. Am J Obstet Gynecol MFM 2021; 3 (05) 100403
• 17 Sullivan LS. Trust, risk, and race in American Medicine. Hastings Cent Rep 2020; 50 (01) 18-26